Quest Diagnostics Inc. (DGX) — Analysis Summary
Quest Diagnostics Inc. (DGX) has a market cap of $21.57B with year-over-year revenue growth of +11.8%. Net margin stands at 9.0%. The stock trades at a P/E ratio of 21.1.
Key Takeaways
- Revenue changed +11.8% year-over-year
- Net margin of 9.0%
- P/E ratio of 21.1
Compared to other companies in the SERVICES-MEDICAL LABORATORIES sector, DGX posted revenue growth of +11.8% and trades at a P/E of 21.1.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.